Teodozyj Kolasa

1.3k total citations
49 papers, 932 citations indexed

About

Teodozyj Kolasa is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Teodozyj Kolasa has authored 49 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Organic Chemistry, 21 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Teodozyj Kolasa's work include Chemical Synthesis and Analysis (11 papers), Analytical Chemistry and Chromatography (7 papers) and Synthesis and Biological Evaluation (6 papers). Teodozyj Kolasa is often cited by papers focused on Chemical Synthesis and Analysis (11 papers), Analytical Chemistry and Chromatography (7 papers) and Synthesis and Biological Evaluation (6 papers). Teodozyj Kolasa collaborates with scholars based in United States, Poland and United Kingdom. Teodozyj Kolasa's co-authors include Marvin J. Miller, A. Chimiak, Meena Patel, Randy L. Bell, Jorge D. Brioni, Robert B. Moreland, Waldemar Wardencki, Andrew O. Stewart, Masaki Nakane and Rodger F. Henry and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Teodozyj Kolasa

49 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teodozyj Kolasa United States 19 538 343 104 78 69 49 932
A. Michael Crider United States 17 542 1.0× 378 1.1× 159 1.5× 70 0.9× 33 0.5× 55 1.0k
E. W. COLLINGTON United Kingdom 18 727 1.4× 324 0.9× 113 1.1× 53 0.7× 42 0.6× 47 1.0k
David G. Melillo United States 14 440 0.8× 289 0.8× 132 1.3× 37 0.5× 20 0.3× 37 939
Antonio Giordani Italy 21 434 0.8× 303 0.9× 191 1.8× 67 0.9× 36 0.5× 37 900
Michael R. Stillings United Kingdom 18 445 0.8× 330 1.0× 134 1.3× 55 0.7× 22 0.3× 33 909
Hans Weidmann Austria 22 1.1k 2.1× 579 1.7× 125 1.2× 39 0.5× 25 0.4× 111 1.5k
David Middlemiss United Kingdom 20 624 1.2× 337 1.0× 54 0.5× 76 1.0× 11 0.2× 45 993
Jan W. F. Wasley Switzerland 17 455 0.8× 483 1.4× 69 0.7× 97 1.2× 28 0.4× 39 1.1k
Samuel Nortey Ghana 15 666 1.2× 387 1.1× 118 1.1× 57 0.7× 302 4.4× 42 1.2k
Bernhard Kutscher Germany 16 284 0.5× 572 1.7× 71 0.7× 23 0.3× 96 1.4× 49 905

Countries citing papers authored by Teodozyj Kolasa

Since Specialization
Citations

This map shows the geographic impact of Teodozyj Kolasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teodozyj Kolasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teodozyj Kolasa more than expected).

Fields of papers citing papers by Teodozyj Kolasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teodozyj Kolasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teodozyj Kolasa. The network helps show where Teodozyj Kolasa may publish in the future.

Co-authorship network of co-authors of Teodozyj Kolasa

This figure shows the co-authorship network connecting the top 25 collaborators of Teodozyj Kolasa. A scholar is included among the top collaborators of Teodozyj Kolasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teodozyj Kolasa. Teodozyj Kolasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Guo Zhu, Pramila Bhatia, Teodozyj Kolasa, et al.. (2006). Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(18). 4936–4940. 18 indexed citations
2.
Patel, Meena, et al.. (2005). Synthesis of 4,5‐Diaryl‐1H‐pyrazole‐3‐ol Derivatives as Potential COX‐2 Inhibitors.. ChemInform. 36(7). 2 indexed citations
3.
Polakowski, James S., Jason A. Segreti, Bryan F. Cox, et al.. (2004). Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats. Clinical and Experimental Pharmacology and Physiology. 31(12). 837–841. 29 indexed citations
4.
Patel, Meena, et al.. (2004). Synthesis of 4,5-Diaryl-1H-pyrazole-3-ol Derivatives as Potential COX-2 Inhibitors. The Journal of Organic Chemistry. 69(21). 7058–7065. 88 indexed citations
5.
Brioni, Jorge D., Masaki Nakane, Gin C. Hsieh, et al.. (2002). Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction. International Journal of Impotence Research. 14(1). 8–14. 45 indexed citations
6.
Kolasa, Teodozyj, et al.. (2001). Dual mechanism of action of nicorandil on rabbit corpus cavernosal smooth muscle tone. International Journal of Impotence Research. 13(4). 240–246. 10 indexed citations
7.
Buckner, Steven A., Ivan Milicic, A.V. Daza, et al.. (2001). A-315456: a selective α1D-adrenoceptor antagonist with minimal dopamine D2 and 5-HT1A receptor affinity. European Journal of Pharmacology. 433(1). 123–127. 9 indexed citations
8.
Kolasa, Teodozyj, David Gunn, Pramila Bhatia, et al.. (2000). Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic Acids as Leukotriene Biosynthesis Inhibitors. Journal of Medicinal Chemistry. 43(4). 690–705. 28 indexed citations
9.
Kolasa, Teodozyj, Pramila Bhatia, Clint D. W. Brooks, et al.. (1997). Synthesis of indolylalkoxyiminoalkylcarboxylates as leukotriene biosynthesis inhibitors. Bioorganic & Medicinal Chemistry. 5(3). 507–514. 6 indexed citations
10.
Kolasa, Teodozyj, Clint D. W. Brooks, James B. Summers, et al.. (1997). Nonsteroidal Anti-Inflammatory Drugs as Scaffolds for the Design of 5-Lipoxygenase Inhibitors. Journal of Medicinal Chemistry. 40(5). 819–824. 18 indexed citations
11.
Kolasa, Teodozyj, et al.. (1996). Synthesis of Fragments of the Peptide Component of Pseudobactin. Journal of Peptide Science. 2(3). 157–164. 1 indexed citations
13.
Brooks, Carter D., Andrew O. Stewart, Ali Basha, et al.. (1995). Preparation of (R)-(+)-N-[3-[5-[(4-Fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propynyl]-N-hydroxyurea (ABT-761), a second-generation 5-lipoxygenase inhibitor.. Journal of Medicinal Chemistry. 38(24). 4768–4775. 32 indexed citations
14.
Kolasa, Teodozyj & Dee W. Brooks. (1993). Practical Synthesis of 2-Acetylbenzo[b]thiophene. Synthetic Communications. 23(6). 743–748. 19 indexed citations
15.
Kolasa, Teodozyj & Marvin J. Miller. (1987). Synthesis of substituted 3-hydroxy-4-alkoxycarbonyl-2-azetidinones. Tetrahedron Letters. 28(17). 1861–1863. 9 indexed citations
16.
Kolasa, Teodozyj & A. Chimiak. (1983). ChemInform Abstract: SYNTHESES OF N‐MONOSUBSTITUTED HYDROXYLAMINES THROUGH O‐BENZYL AND O‐(P‐METHOXY)BENZYL DERIVATIVES. Chemischer Informationsdienst. 14(11). 1 indexed citations
18.
Kolasa, Teodozyj & Erhard Gross. (1982). Dehydroaspartic acid derivatives*. International journal of peptide & protein research. 20(3). 259–266. 4 indexed citations
19.
Kolasa, Teodozyj & A. Chimiak. (1977). Unambiguous synthesis of n-hydroxypeptides. Tetrahedron. 33(24). 3279–3284. 20 indexed citations
20.
Kolasa, Teodozyj & Waldemar Wardencki. (1974). Quantitative determination of hydroxylamine. Talanta. 21(8). 845–857. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026